HEC vs. PIII, EUDA, SHCR, HYAC, DCGO, WGS, INNV, VXRT, DBVT, and FTLF
Should you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include P3 Health Partners (PIII), EUDA Health (EUDA), Sharecare (SHCR), Haymaker Acquisition Corp. III (HYAC), DocGo (DCGO), GeneDx (WGS), InnovAge (INNV), Vaxart (VXRT), DBV Technologies (DBVT), and FitLife Brands (FTLF).
P3 Health Partners (NASDAQ:PIII) and Hudson Executive Investment (NASDAQ:HEC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, community ranking, risk, profitability, media sentiment, valuation and dividends.
P3 Health Partners received 4 more outperform votes than Hudson Executive Investment when rated by MarketBeat users.
P3 Health Partners presently has a consensus price target of $4.75, suggesting a potential upside of 555.26%. Given Hudson Executive Investment's higher probable upside, research analysts plainly believe P3 Health Partners is more favorable than Hudson Executive Investment.
Hudson Executive Investment has a net margin of 0.00% compared to Hudson Executive Investment's net margin of -4.56%. Hudson Executive Investment's return on equity of -120.85% beat P3 Health Partners' return on equity.
In the previous week, P3 Health Partners had 2 more articles in the media than Hudson Executive Investment. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for Hudson Executive Investment. P3 Health Partners' average media sentiment score of 0.00 beat Hudson Executive Investment's score of -0.33 indicating that Hudson Executive Investment is being referred to more favorably in the news media.
Hudson Executive Investment has lower revenue, but higher earnings than P3 Health Partners.
7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 73.4% of Hudson Executive Investment shares are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
P3 Health Partners beats Hudson Executive Investment on 7 of the 12 factors compared between the two stocks.
Get Hudson Executive Investment News Delivered to You Automatically
Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hudson Executive Investment Competitors List
Related Companies and Tools
